Home › Funds › Rosalind Advisors, Inc. › SVRA

Rosalind Advisors, Inc. position in SVRA

Savara Inc · Health Care

Rosalind Advisors, Inc. reported holding 3,178,121 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$19.6M, representing 7.28% of its reported portfolio and ranking #4 among its reported holdings. Rosalind Advisors, Inc. has disclosed SVRA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)3.18M sh
Reported value held$19.58M
Portfolio Weight7.28%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rosalind Advisors, Inc.'s SVRA position evolved

Rosalind Advisors, Inc. first disclosed a stake in SVRA in Q4 2024 at 2,654,944 shares (US$8.2M). The position peaked in Q4 2025 at 3,403,721 shares, worth US$20.5M. Across 7 filings, Rosalind Advisors, Inc. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 3,178,121 shares valued at US$19.6M — a reduction of -25,600 shares quarter over quarter.. Notable position changes include a 51% increase in Q3 2025 (shares rose 69% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.65M $8.15M New
Q1 2025 2.65M $7.35M Hold
Q2 2025 2.65M $6.05M Hold
Q3 2025 4.00M $14.28M Add
Q4 2025 3.40M $20.52M Reduce
Q1 2026 3.20M $17.49M Reduce
Q2 2026 3.18M $19.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Rosalind Advisors, Inc. held SVRA?

Rosalind Advisors, Inc. has disclosed SVRA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Rosalind Advisors, Inc.'s current position in SVRA?

As of Q2 2026, Rosalind Advisors, Inc. holds 3.18M shares of SVRA (Savara Inc), valued at $19.58M, representing 7.28% of its reported portfolio and ranking #4.

Has Rosalind Advisors, Inc. been buying or selling SVRA?

In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. reduced its position in SVRA. The position peaked in Q4 2025 at 3.40M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.